Dysregulation of DKC1 in certain cancer types leads to aberrant ribosome biogenesis and impaired protein synthesis, resulting in a tumor-suppressive effect by impairing cell proliferation and promoting cell cycle arrest. Here, DKC1 is linked to neoplasm.